Zepp Health Corporation v. Slyde Analytics, LLC

IPR2024-00833

The IPR was terminated after the parties settled following institution.

Jurisdiction
US PTAB
Case Number
IPR2024-00833
Decision Date
22 April 2024
Filing Date
22 April 2024

Detailed Summary

In IPR2024-00833, Zepp Health Corporation challenged U.S. Patent No. 8,588,033 owned by Slyde Analytics, LLC. After the Board instituted the trial, the parties reached a settlement, leading to a termination of the proceeding. No substantive claim constructions or unpatentability findings were issued.

Practitioner Note

This case demonstrates the evidentiary and procedural standards applied in patent matters before local courts. Understanding the court's reasoning in Zepp Health Corporation vs Slyde Analytics, LLC is valuable context for structuring arguments or assessing risk in similar proceedings.

Related Cases

patentIPR2026-00018

Samsung Electronics Co., Ltd. et al.vsNetlist, Inc.

Samsung successfully challenged claim 16 of Netlist’s ’912 memory‑module patent, with the PTAB finding the claim obvious over the Ellsberry reference and unpatentable.

patentIPR2024-01133

BOE Technology Group Co., LTDvsOptronic Sciences, LLC

BOE Technology Group Co., LTD successfully petitioned to institute IPR proceedings against Optronic Sciences, LLC regarding display technology patents. The Board granted institution after a favorable claim construction of 'auxiliary electrode,' finding the petitioner demonstrated a reasonable likelihood of prevailing on key grounds.

patentIPR2026-00286

Google LLCvsAccuSearch Technologies LLC

Google filed an IPR petition seeking cancellation of all 25 claims of AccuSearch’s ’959 patent covering annotated search‑result displays, arguing obviousness over multiple prior‑art references.

patentIPR2026-00043

American Airlines, Inc. et al.vsIntellectual Ventures II LLC

The PTAB denied American Airlines and Southwest Airlines’ petition to institute an IPR against Intellectual Ventures’ ’326 patent covering high‑data‑rate multi‑channel WLAN. The Board found no reasonable likelihood of success on any of the 18 challenged claims.

patentPGR2026-00042

Wealth, Inc.vs--

Wealth, Inc. has filed a Post‑Grant Review petition seeking cancellation of all 20 claims of Vanilla Technologies’ U.S. Patent 12,353,917, alleging ineligibility, obviousness, indefiniteness, and an improper dependent claim. The petition relies on prior‑art references Racanelli, Bateman, Dintenfass, McMillen and Kwak.

Arctic Invent — IP Strategy

Dealing with a patent challenge?

Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.

Talk to our patent team →

Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.

Strategy Consult

Facing a similar patent matter?

Arctic's litigation team uses precedent data like this to build winning arguments.

Get a Strategy Call